Summit Therapeutics plc (SMMT): $6.42

-0.05 (-0.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Summit Therapeutics Inc (SMMT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Summit Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $5 $4 $4.5 $6.56 -31.4%

The Trend in the Analyst Price Target


SMMT's average price target has moved up $0.5 over the prior 113 days.

Over the past 13 months, SMMT's average upside potential has been -28.08%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 2 5 4 4.5 6.82 -34.02%
2021-06-05 2 5 4 4.5 8.00 -43.75%
2021-05-22 2 5 4 4.5 8.46 -46.81%
2021-05-15 2 5 4 4.5 5.41 -16.82%
2021-05-08 2 5 4 4.5 5.82 -22.68%
2021-04-25 2 5 4 4.5 5.60 -19.64%
2021-04-17 2 5 4 4.5 5.36 -16.04%
2021-04-10 2 5 4 4.5 5.63 -20.07%
2021-04-03 2 5 4 4.5 6.14 -26.71%
2021-03-20 2 5 4 4.5 6.04 -25.5%
2021-03-13 2 5 4 4.5 6.47 -30.45%
2021-03-06 2 5 4 4.5 5.67 -20.63%
2021-02-27 2 5 4 4.5 6.77 -33.53%
2021-02-20 1 4 4 4.0 7.33 -45.43%
2021-02-13 1 4 4 4.0 7.70 -48.05%
2021-02-06 1 4 4 4.0 8.96 -55.36%
2021-01-30 1 4 4 4.0 6.96 -42.53%
2021-01-23 1 4 4 4.0 5.59 -28.44%
2021-01-16 1 4 4 4.0 5.30 -24.53%
2021-01-09 1 4 4 4.0 5.19 -22.93%
2021-01-02 1 4 4 4.0 4.70 -14.89%
2020-12-26 1 4 4 4.0 5.70 -29.82%
2020-12-19 1 4 4 4.0 5.56 -28.06%
2020-12-10 1 4 4 4.0 4.84 -17.36%
2020-12-07 1 4 4 4.0 4.99 -19.84%
2020-11-28 2 5 4 4.5 4.34 3.69%
2020-06-01 1 4 4 4.0 NA NA%

SMMT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 1 1 0 0 3

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SMMT as an investment opportunity.

  • The upside potential (average analyst target price relative to current price) of SMMT is greater than 6.09% of all US stocks.
  • The average analyst price target of SMMT is greater than 7.11% of all US stocks.
  • Summit Therapeutics Inc's number of analysts covering the stock is higher than 13.67% of Pharmaceutical Products stocks.
  • SMMT has a lower variance in analysts' estimates than 73.38% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, OGI, PLXP and ANIP are the three stocks most similar to Summit Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is SMMT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7876 seconds.